Protein Crystallography in Vaccine Research and Development

Enrico Malito1, Andrea Carfi2, Matthew J Bottomley3

  • 1Protein Biochemistry Department, Novartis Vaccines & Diagnostics s.r.l. (a GSK Company), Via Fiorentina 1, 53100 Siena, Italy. enrico.x.malito@gsk.com.

Summary

Protein crystallography, a key tool in drug design, is now revolutionizing vaccine development. Structural insights are enabling the rational design of novel and optimized vaccine antigens for improved efficacy.